Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 22,200 shares at $35.99 ($782K) on 2021-02-18, disclosed to the SEC on 2021-02-22.
Open-market sale of $782k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.19 | 2,647 | $91K | 11.6% |
| 2 | $34.19 | 2,647 | $91K | 11.6% |
| 3 | $35.02 | 4,553 | $159K | 20.4% |
| 4 | $35.02 | 4,553 | $159K | 20.4% |
| 5 | $35.99 | 6,400 | $230K | 29.4% |
| 6 | $36.92 | 1,000 |
| $37K |
| 4.7% |
| 7 | $37.88 | 400 | $15K | 1.9% |
| Total | $35.24 avg | 22,200 | $782K | 100% |
| Filing → |
| NRIX | SELL | 2021-06-11 | $220K | — | Filing → |
| NRIX | SELL | 2021-05-11 | $378K | — | Filing → |
| NRIX | SELL | 2021-04-13 | $394K | — | Filing → |